- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aarti Drugs Ltd (ADRG)
Aarti Drugs Ltd stock price live, this page displays NSE ADRG stock exchange data. View the ADRG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aarti Drugs Ltd real time stock price chart below.
What Is the Aarti Drugs Ltd Stock Price Today?
The Aarti Drugs Ltd stock price today is 480.60.
What Is the Stock Symbol for Aarti Drugs Ltd?
The stock symbol for Aarti Drugs Ltd is "ADRG."
What Stock Exchange Does Aarti Drugs Ltd Trade On?
Aarti Drugs Ltd is listed and trades on the NSE stock exchange.
Is Aarti Drugs Ltd a Good Stock to Buy?
Determining whether Aarti Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADRG quote. (ISIN: INE767A01016)
What Is the Aarti Drugs Ltd Stock Price Today?
The Aarti Drugs Ltd stock price today is 480.60.
What Is the Stock Symbol for Aarti Drugs Ltd?
The stock symbol for Aarti Drugs Ltd is "ADRG."
What Stock Exchange Does Aarti Drugs Ltd Trade On?
Aarti Drugs Ltd is listed and trades on the NSE stock exchange.
Is Aarti Drugs Ltd a Good Stock to Buy?
Determining whether Aarti Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADRG quote. (ISIN: INE767A01016)
480.60
+25.65(+5.64%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
458.10
490.00
52 wk Range
312.00
635.00
ADRG Scorecard
Full Analysis
Management has been aggressively buying back shares
ADRG is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
458.10490.00
52 wk Range
312.00635.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ADRG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
No news in this category
Looks like there are no results in this news category
Aarti Drugs Ltd Company Profile
Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Compare ADRG to Peers and Sector
Metrics to compare | ADRG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADRGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.5x | 28.9x | −0.5x | |
PEG Ratio | −16.60 | 0.72 | 0.00 | |
Price/Book | 3.3x | 3.6x | 2.6x | |
Price / LTM Sales | 1.9x | 3.2x | 3.0x | |
Upside (Analyst Target) | −4.1% | 10.8% | 54.1% | |
Fair Value Upside | Unlock | −5.1% | 8.7% | Unlock |
Earnings
Latest Release
May 06, 2025
EPS / Forecast
6.90 / --
Revenue / Forecast
6.77B / --
People Also Watch
FAQ
What Is the Aarti Drugs Ltd (ADRG) Stock Price Today?
The Aarti Drugs Ltd stock price today is 480.60
What Stock Exchange Does Aarti Drugs Ltd Trade On?
Aarti Drugs Ltd is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Aarti Drugs Ltd?
The stock symbol for Aarti Drugs Ltd is "ADRG."
Does Aarti Drugs Ltd Pay Dividends? What’s The Current Dividend Yield?
The Aarti Drugs Ltd dividend yield is 0.21%.
What Is the Aarti Drugs Ltd Market Cap?
As of today, Aarti Drugs Ltd market cap is 44.26B.
What Is Aarti Drugs Ltd's Earnings Per Share (TTM)?
The Aarti Drugs Ltd EPS (TTM) is 18.35.
When Is the Next Aarti Drugs Ltd Earnings Date?
Aarti Drugs Ltd will release its next earnings report on 23 July 2025.
From a Technical Analysis Perspective, Is ADRG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.